STRS Ohio’s Immuneering IMRX Stock Holding History

STRS Ohio’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,900	Closed	-$12K	–	2156
2022 Q1	$12K	Hold	1,900	–	–	﹤0.01%	2077
2021 Q4	$30K	Hold	1,900	–	–	﹤0.01%	2066
2021 Q3	$50K	Buy	+1,900	New	+$51.1K	﹤0.01%	2069

Other funds holding IMRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BSW

Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

STRS Ohio's IMRX Position: Q2 2022 in Review

STRS Ohio sold out of Immuneering (IMRX) in Q2 2022, closing a stake of 1,900 shares — an estimated $12K sold.

STRS Ohio first reported a position in IMRX in Q3 2021 and held it in 3 quarters. The position peaked at $50K in Q3 2021. 37 funds tracked by Wall St. Rank hold IMRX as of Q2 2022.

STRS Ohio reported no remaining Immuneering position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 1,900 Immuneering shares in Q2 2022, an estimated $12K.
STRS Ohio first reported a position in Immuneering in Q3 2021 and held it in 3 quarters.
STRS Ohio's Immuneering position peaked at $50K in Q3 2021.
37 funds tracked by Wall St. Rank held Immuneering as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.